ClinicalTrials.Veeva

Menu

East-West Collaborative Medicine Using Bee-Venom Acupuncture on Whiplash-Associated Disorders

K

Korean Pharmacoacupuncture Institute

Status

Unknown

Conditions

Whiplash Injuries

Treatments

Device: Bee Venom Acupuncture Therapy
Drug: zaltoprofen

Study type

Interventional

Funder types

Other

Identifiers

NCT01369238
KOMC 2010-04

Details and patient eligibility

About

  1. Purpose of study

    1. To evaluate the efficacy of East-West collaborative medicine using Bee-Venom Acupuncture Therapy on Whiplash-Associated Disorders using VAS scale
    2. To evaluate the efficacy of East-West collaborative medicine using Bee-Venom Acupuncture Therapy on Whiplash-Associated Disorders using NDI, BDI, SF-36, and EQ-5D.
  2. Interventions & Groups

    1. group 1: Bee-Venom Acupuncture Therapy
    2. group 2: zaltoprofen
    3. group 3: Bee-Venom Acupuncture Therapy & zaltoprofen

Enrollment

90 estimated patients

Sex

All

Ages

25 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • clinical diagnosis of Whiplash injuries
  • Must have cervicalgia of more than VAS 5

Exclusion criteria

  • cancer, osteoporosis, ankylosing spodylitis, cauda equina syndrome, infection
  • spinal operation
  • other musculoskeletal pain
  • physicological or mental disorders

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

90 participants in 3 patient groups

Bee Venom Acupuncture & zaltoprofen
Experimental group
Treatment:
Drug: zaltoprofen
Device: Bee Venom Acupuncture Therapy
zaltoprofen
Active Comparator group
Treatment:
Drug: zaltoprofen
Bee Venom Acupuncture
Active Comparator group
Treatment:
Device: Bee Venom Acupuncture Therapy

Trial contacts and locations

0

Loading...

Central trial contact

Koh-Woon Kim

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems